LIVN — LivaNova PLC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1639691 ·
United Kingdom
Last close
$91.92
Market Cap
$5.06B
52W High
$99.38
52W Low
$52.37
ADV30
723,153
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 393,148,000 | 265,051,000 | 28,425,000 | 34,294,000 | 2,713,124,000 | 563,467,000 | 1,341,053,000 |
| Jun 2026 | 390,587,000 | 273,670,000 | 49,484,000 | 108,569,000 | 2,640,861,000 | 516,619,000 | 1,315,539,000 |
| Mar 2026 | 362,258,000 | 243,749,000 | 41,471,000 | 22,294,000 | 2,516,351,000 | 539,706,000 | 1,305,025,000 |
| Dec 2025 | 360,921,000 | 239,773,000 | 42,578,000 | 30,906,000 | 2,606,053,000 | 635,552,000 | 1,406,066,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$237,864,000
Investing CF
$-99,865,000
Financing CF
$-216,495,000
CapEx
$-108,847,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$3.00
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-980,564,000
Inventory
$177,881,000
Receivables
$282,647,000
ST Investments
—
EBIT TTM
$154,648,000
Pretax Income TTM
$120,372,000
Interest Exp TTM
$34,276,000
Analysts
11
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,506,914,048
EBITDA
$271,267,008
Free Cash Flow
$67,713,376
Enterprise Value
$4,750,865,920
Total Cash
$563,467,008
Total Debt
$357,071,008
Shares Out
55,086,809
Trailing EPS
$3.49
Book Value
$24.91
ROE
15.5%
ROA
5.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,388,053,000 | 199,390,000 | -242,471,000 | 2,606,053,000 | 1,406,066,000 | 1,199,987,000 | 254,340,000 |
| Dec 2024 | 1,253,437,000 | 129,051,000 | 63,234,000 | 2,506,389,000 | 1,186,131,000 | 1,320,258,000 | 183,038,000 |
| Dec 2023 | 1,153,545,000 | 21,476,000 | 17,546,000 | 2,429,563,000 | 1,151,935,000 | 1,277,628,000 | 74,914,000 |
| Dec 2022 | 1,021,805,000 | 52,644,000 | -86,246,000 | 2,294,773,000 | 1,087,149,000 | 1,207,624,000 | 69,921,000 |
TTM Snapshot
Revenues TTM
$1,471,519,000
NetIncome TTM
$188,553,000
OpCashFlow TTM
—
Assets (Latest)
$2,640,861,000
Forward EPS
$4.72
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $95.00 · spot: $94.54 · call volume: 646 · put volume: 263
Expected Move to 2026-12-18:
±$8.22
(8.70%) —
implied range
$86.32 –
$102.77
· ATM straddle on $95.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MMSI | MERIT MEDICAL SYSTEMS INC | $5.06B | $84.49 | — |
| MMED | MiniMed Group, Inc. | $5.00B | $17.78 | — |
| HAE | HAEMONETICS CORP | $5.51B | $120.92 | — |
| ICUI | ICU MEDICAL INC/DE | $4.42B | $176.91 | — |
| ITGR | Integer Holdings Corp | $4.32B | $126.97 | — |
News headlines (Yahoo Finance, 1h cache)
Medical costs are crushing insurers—and lifting LivaNova stock
2026-11-18 07:24 · Yahoo
LivaNova Stock Gets Lift From Strong Earnings And Epilepsy Study Results
2026-11-05 04:39 · Yahoo
LivaNova PLC Q3 2026 Earnings Call Summary
2026-11-04 23:07 · Yahoo
LivaNova (LIVN) Q3 2026 Earnings Call Transcript
2026-11-04 18:29 · Yahoo
LivaNova Q3 Earnings Call Highlights
2026-11-04 18:14 · Yahoo
LivaNova (LIVN) Reports Q3 Earnings: What Key Metrics Have to Say
2026-11-04 13:30 · Yahoo
LivaNova (LIVN) Surpasses Q3 Earnings and Revenue Estimates
2026-11-04 11:20 · Yahoo
LivaNova: Q3 Earnings Snapshot
2026-11-04 11:19 · Yahoo
LivaNova Reports Third-Quarter 2026 Results; Raises Full-Year 2026 Revenue and Adjusted Diluted EPS Guidance
2026-11-04 11:00 · Yahoo
Neuromodulation Publishes Full 36-Month CORE-VNS Results Demonstrating Sustained and Increasing Benefits of LivaNova’s VNS Therapy for Drug-Resistant Epilepsy
2026-10-23 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.